8 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)Advanced Non-small Cell Lung Cancer, HER2 MutationRecruitingPhase 32026-09-23NCT06452277
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple MyelomaBlood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseRecruitingPhase 32026-09-11NCT07555938
Clinical Study of HRS-2129 for Acute Gouty ArthritisAcute Gouty ArthritisRecruitingPhase 22026-09-03NCT07706777
A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer.High-risk Localized Prostate CancerRecruitingPhase 22026-08-10NCT07450599
Machine Learning-Guided LIV Selection for Adolescent Idiopathic Scoliosisadolescent idiopathic scoliosisNot yet recruitingNot applicable2026-07-23NCT07723053
Efficacy and Safety of a Novel ERCP Robot in the Treatment of Common Bile Duct StoneCalculi, Digestive System Diseases, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, biliary tract disorder, cholecystolithiasis, cholelithiasis, gallbladder disorder, gallstonesActive, not recruitingNot applicable2026-01-26NCT07368335
FAD Subtype-Guided Combination Therapy for Unresectable Hepatocellular CarcinomaDigestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasmNot yet recruitingPhase 22026-01-20NCT07314372
Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate PhaseBlood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adenocarcinoma, carcinoma, chronic hepatitis B virus infection, epithelial neoplasm, hepatitis, hepatitis B virus infection, hepatocellular carcinoma, infectious disease, liver disorder, neoplasm, viral hepatitis, viral infectious diseaseRecruitingNot stated2022-12-22NCT05661786